Grey Street Capital »

Rxsight shares owned by Grey Street Capital

Quarter-by-quarter ownership of Rxsight (RXST) shares owned by Grey Street Capital from 13F filings

Historical chart of Grey Street Capital investment in Rxsight

Tip: Access up to 7 years of quarterly data

All positions including Rxsight held by Grey Street Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rxsight by Grey Street Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $765k 19k 40.32

More positions owned by Grey Street Capital

Eli Lilly & Co. (LLY)
Vertex Pharmaceuticals Incorporated (VRTX)
Accenture Plc Ireland Shs Class A (ACN)
Amazon (AMZN)
Adobe Systems Incorporated (ADBE)
Agnico (AEM)
Alamos Gold Com Cl A (AGI)
Goldman Sachs (GS)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Cable One (CABO)
Crowdstrike Hldgs Cl A (CRWD)
Block Cl A (SQ)
Equity Lifestyle Properties (ELS)

View all positions for Grey Street Capital

Top funds holding Rxsight

RA Capital Management
Artisan Partners Limited Partnership
Lord, Abbett & Co
Vanguard Group
Deutsche Bank Aktiengesellschaft
Jpmorgan Chase & Co
Bank of America Corporation
No Street GP
Millennium Management
Two Sigma Advisers
Voloridge Investment Management
Two Sigma Investments
Federated Investors
Point72 Asset Management
Russell Investments

View all funds holding Rxsight